To assess the effects of medications for daytime sleepiness and related symptoms in individuals with idiopathic hypersomnia, and in particular whether medications may:
- reduce subjective measures of sleepiness;
- reduce objective measures of sleepiness;
- reduce symptoms of cognitive dysfunction;
- improve quality of life; and
- be associated with adverse events.
This is a protocol.